Degos disease is rare, complex and often misunderstood; however, we’ve gathered the key facts and real case insights to make it clear for you.1 Whether it shows up in the classic form or with unusual symptoms, we can explain what’s going on and why it matters.
Atypical presentations of Degos disease are cases that don’t follow the usual pattern of skin lesions plus gastrointestinal and/or neurological problems. They may involve:
- Different skin lesion appearances — such as ulcers or unusual locations2
- Systemic disease without skin involvement — affecting the gut, brain, or other organs first2
- Rare organ involvement — lungs, heart, kidneys, eyes or ears3
- Paediatric onset — often more severe or multi-system from the start (children often get sicker faster)4,5
Recognising and remembering these variations is essential because they can delay diagnosis and treatment. Biopsy remains the standard for confirmation, and early multidisciplinary management improves the outlook.
Introduction
Degos disease (also known as malignant atrophic papulosis) is an extremely rare vascular disorder with only around 200 cases reported in the medical literature.4 Bet these numbers made you not worry about being affected by this condition! It is characterised by small and medium blood vessel blockage (vasculopathy), leading to the blood flow being cut off, which causes patches of tissue to die. Classically, Degos disease presents with distinctive skin lesions (porcelain-white, atrophic centres in papules with red rims) accompanied by gastrointestinal and often central nervous system involvement. However, not all patients follow this classic pattern. Some cases show unusual or “atypical” features in their presentation.2 In this article, we are going to educate you on these atypical case reports and discuss the clinical lessons they offer. Our article aims to highlight the importance of recognising Degos disease even when it doesn’t fit the textbook description.
Typical Degos Disease Overview
Degos disease occurs in two forms: a benign (safe) skin form confined to the skin and a systemic form involving internal organs.5 In the benign form (also called benign atrophic papulosis), patients develop scattered skin lesions. Those are small red bumps that evolve into papules with a porcelain-white, atrophic centre and a telangiectatic (red) border.2 These lesions are usually on the trunk and limbs and rarely on the face or hands.4 They often appear in crops and can precede other symptoms by months or years. In contrast, the malignant systemic form (malignant atrophic papulosis) includes the same skin lesions plus internal organ involvement, which is a bit scary. Most frequently, the gastrointestinal (GI) tract and central nervous system (CNS) are involved.2 Systemic Degos can lead to serious complications like intestinal leak, bowel perforations or seizures.1,6,7 Unfortunately, systemic cases carry a poor prognosis: studies report an average survival of only about 2-3 years and a five-year survival rate under 50% without effective treatment. By comparison, patients with skin-only (benign) Degos often have a much better outlook and can survive long term.4
Defining ‘Atypical’ in Degos Disease
In the context of Degos disease, an atypical presentation means any case that is different from the expected clinical pattern. Classic Degos involves features such as: skin papules with porcelain-white centres, GI tract infarcts (often leading to abdominal pain or perforations) and frequently CNS involvement (such as strokes or neurological deficits).2
Notable Atypical Case Reports
Skin lesion variations
Even the cutaneous signs of Degos disease can sometimes stray from the classic description. Typically, Degos papules are a few millimetres to 1 cm in size with an umbilicated porcelain-white centre and red border, and they usually heal into round, atrophic white scars.4 However, case reports show that lesions can vary in form and behaviour. In one pediatric case, for example, the skin lesions began as red papules that enlarged into painful ulcers before healing and leaving porcelain-white scarred centres.5 There are also reports of atypical lesion locations. Whereas Degos lesions classically spare the face, hands and feet, some patients have developed papules on the face, scalp, or other unusual sites. Such variations can confuse clinicians, since lesions in an unexpected location or with an atypical appearance might not immediately be recognised as Degos.4
Systemic without skin involvement
One of the most challenging atypical patterns is when Degos disease affects internal organs without any obvious skin signs. Normally, the skin lesions act as an early warning sign, often appearing months or years before systemic complications.5 But in rare instances, patients have presented with catastrophic internal issues (like bowel perforations or CNS events) before any skin lesions were noted.5 GI-only presentations can be initially mistaken for disorders like Crohn’s disease.8,9 The absence of skin lesions delays correct diagnosis because Degos is usually not considered until the classic rash appears.4
Rare organ involvement
Beyond the skin, gut, and brain, Degos disease can occasionally involve other organ systems. Published case reports and reviews have documented Degos-related damage in the lungs, heart, pleura, kidneys, and eyes. For instance, some systemic cases feature fluid build-up around the lungs (pleural effusion) or inflammation of the lung tissue (pneumonitis), and some have fluid around the heart (pericardial effusion). In other cases, the condition can affect the kidneys, leading to swelling or changes in how well they filter waste, and it can also affect the eyes, causing redness, pain, or blurred vision.3
Pediatric onset cases
Degos disease is exceedingly rare in children, but when it does occur, it often qualifies as an atypical presentation due to differences from the adult pattern. To date, only around 30-40 pediatric cases have been documented in the literature.4,5
Interestingly, evidence suggests that multisystem involvement is more prevalent in children – pediatric Degos patients tend to develop systemic disease (malignant form) more often than adults do 5. In other words, Degos in a child is more likely to be the severe, organ-threatening type rather than the benign skin-only type (and there appears to be a male predominance among affected children as well).5
Diagnostic Challenges
Identifying Degos disease can be challenging, especially in atypical or early-stage cases, and misdiagnosis is a common risk. For example, the skin findings of early Degos (red inflammatory papules) can mimic lupus erythematosus or other cutaneous autoimmune diseases.2
Problems in the gut might seem like Crohn’s disease8,9 or intestinal tuberculosis at first, and the tell-tale skin spots can be small, painless, or hardly noticeable. If doctors don’t connect these unusual skin changes with other unexplained symptoms. For example, ongoing gut problems or issues in other organs. This way, the disease may not be recognised until it’s advanced, when treatment options are limited and the outlook is much worse. As one case report concluded, the diagnosis was delayed because the team “ignored the relation between skin changes and peritonitis”.4
Clinical Implications & Management
Managing Degos disease requires a multidisciplinary strategy tailored to the patient’s specific pattern of involvement. Because the disease can affect the skin, GI tract, CNS and potentially other organs. Supervision under dermatologists, gastroenterologists, neurologists, rheumatologists and others may be needed. Patients benefit from coordinated care, so for example, dermatology to monitor and biopsy skin lesions, gastroenterology or surgery to address intestinal issues and neurology for CNS manifestations. Close monitoring is essential: experts recommend regular check-ups to catch any new organ involvement early.5 In fact, one follow-up protocol suggests comprehensive skin exams (with biopsy of new lesions) and periodic endoscopic evaluations (colonoscopy, gastroscopy, or even prophylactic laparoscopy) for several years, especially in patients known to have only cutaneous Degos, to ensure that any transition to systemic disease is detected promptly.4
Future Directions
Because Degos disease is so rare, advancing our understanding and treatment of it will likely require global work. Larger case databases and registries could help researchers compile enough data to spot patterns. For example, identifying predictors of who will develop systemic involvement, or which treatments seem most effective long-term. At present, much of our knowledge comes from isolated case reports or small series (sometimes as few as a handful of patients), which isn’t ideal for drawing firm conclusions.3
Summary
Degos disease is a very rare and complicated condition that affects the blood vessels. While it usually shows up as specific skin spots along with serious problems in the gut and brain, this isn't always the case. The disease can have "atypical" presentations, meaning it doesn't follow the usual pattern. This can make it tricky for doctors to diagnose, especially when the symptoms are different. For example, some patients might have odd-looking skin lesions. Others might not have any skin spots at all, with the disease only affecting internal organs like the heart, lungs, or kidneys. In children, the disease also tends to be more severe. Because Degos disease can affect so many parts of the body, doctors from different specialities have to work together to treat it. By learning more about these unusual cases, medical professionals will be able to catch the disease earlier and improve the chances of a better outcome for patients.
FAQs
Is Degos disease always fatal?
No, not always, but the malignant form of the condition tends to have bad outcomes. So, Degos disease can sometimes be limited to the skin (benign form), in which case patients may live a normal lifespan with proper monitoring. However, the systemic form is very serious. Historically, it has a high mortality, with a median survival of only 2-3 years in untreated cases.4
Can you inherit Degos disease?
So while it is not definitively established as something you can inherit, published reports do indicate that some cases run in families and that an inherited predisposition is possible.10,11
References
- Degos Disease - an overview | ScienceDirect Topics [Internet]. [cited 2025 Aug 15]. Available from: https://www.sciencedirect.com/topics/medicine-and-dentistry/degos-disease.
- Pukhalskaya T, Stiegler J, Scott G, Richardson CT, Smoller B. Degos Disease (Malignant Atrophic Papulosis) With Granular IgM on Direct Immunofluorescence. Cureus [Internet]. [cited 2025 Aug 15]; 13(1):e12677. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7880853/.
- Pirolla E, Fregni F, Miura IK, Misiara AC, Almeida F, Zanoni E. Degos disease – malignant atrophic papulosis or cutaneointestinal lethal syndrome: rarity of the disease. Clin Exp Gastroenterol [Internet]. 2015 [cited 2025 Aug 15]; 8:141–7. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4403817/.
- Shi X-W, Deng J-H, Li C-F. Case Report: Infant-onset Degos disease with nervous system involvement and a literature review. Front Pediatr [Internet]. 2024 [cited 2025 Aug 15]; 12. Available from: https://www.frontiersin.org/journals/pediatrics/articles/10.3389/fped.2024.1374150/full.
- Sundaram M, Thamotharan N, Swaminathan A, Rangarajan S, Muralidhar K. Dreaded Degos Disease in Childhood. Cureus. 2025; 17(1):e76844.
- Degos Disease - Symptoms, Causes, Treatment | NORD [Internet]. [cited 2025 Aug 15]. Available from: https://rarediseases.org/rare-diseases/degos-disease/.
- Sattler SS, Magro CM, Shapiro L, Merves JF, Levy R, Veenstra J, et al. Gastrointestinal Kohlmeier–Degos disease: a narrative review. Orphanet Journal of Rare Diseases [Internet]. 2022 [cited 2025 Aug 15]; 17(1):172. Available from: https://doi.org/10.1186/s13023-022-02322-9.
- Loewe R, Palatin M, Petzelbauer P. Degos disease with an inconspicuous clinical course. Acad Dermatol Venereol [Internet]. 2005 [cited 2025 Aug 15]; 19(4):477–80. Available from: https://onlinelibrary.wiley.com/doi/10.1111/j.1468-3083.2004.01181.x.
- Castanet J, Lacour JP, Perrin C, Rodot S, Ortonne JP. Cutaneous vasculitis with lesions mimicking degos’ disease and revealing Crohn’s disease. Acta Dermato-Venereologica [Internet]. 1995 [cited 2025 Aug 15]; 75(5):408–9. Available from: https://medicaljournalssweden.se/actadv/article/view/15265.
- Paller AS, Mancini AJ. 22 - Collagen Vascular Disorders. In: Paller AS, Mancini AJ, editors. Hurwitz Clinical Pediatric Dermatology (Fourth Edition) [Internet]. London: W.B. Saunders; 2011 [cited 2025 Aug 15]; p. 497–527. Available from: https://www.sciencedirect.com/science/article/pii/B9781437704129000228.
- Nouh A, Speiser J, Biller J. Chapter 3 - Acquired neurocutaneous disorders. In: Islam MP, Roach ES, editors. Handbook of Clinical Neurology [Internet]. Elsevier; 2015 [cited 2025 Aug 15]; bk. 132, p. 29–73. Available from: https://www.sciencedirect.com/science/article/pii/B9780444627025000032.

